Stockscreener 앱 받기
1.29
1.59%
0.03
전일 마감가:
$1.26
열려 있는:
$1.13
하루 거래량:
418.01K
Relative Volume:
0.32
시가총액:
$14.41M
수익:
$516.00K
순이익/손실:
$-14.20M
주가수익비율:
-0.4045
EPS:
-3.1891
순현금흐름:
$-5.83M
1주 성능:
-25.58%
1개월 성능:
-46.44%
6개월 성능:
-12.93%
1년 성능:
-45.06%
1일 변동 폭
$1.13
$1.30
1주일 범위
$0.98
$2.28
52주 변동 폭
$0.98
$6.15
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
MGRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.29 | 14.41M | 516.00K | -14.20M | -5.83M | -3.1891 |
|
VEEV
Veeva Systems Inc
|
275.31 | 45.40B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
67.41 | 11.81B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
48.16 | 8.86B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
103.04 | 8.63B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.87 | 6.56B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
It is Poised to be a Bull Market for Mangoceuticals Inc (MGRX) - setenews.com
Is Mangoceuticals Inc. stock entering bullish territoryJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Why Mangoceuticals Inc. is moving todayWatch List & Real-Time Volume Trigger Notifications - newser.com
Can technical indicators confirm Mangoceuticals Inc.’s reversal2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Can Mangoceuticals Inc. rally from current levelsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Can Mangoceuticals Inc. stock rebound after recent weakness2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
Evaluating Mangoceuticals Inc. with trendline analysisLayoff News & Weekly Momentum Stock Picks - newser.com
Novo denies partnership with Mangoceuticals on obesity drug, Reuters says - MSN
Will Mangoceuticals Inc. benefit from macro trendsJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com
Can Mangoceuticals Inc. stock reach $100 price targetLong Setup & AI Enhanced Trade Execution Alerts - newser.com
Can Mangoceuticals Inc. stock sustain free cash flow growth2025 Price Action Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Mangoceuticals Inc. stock supported by strong fundamentalsJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MANGOCEUTICALS, INC. SEC 10-Q Report - TradingView
Can Mangoceuticals Inc. stock withstand economic slowdown2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Will Mangoceuticals Inc. stock deliver shareholder valueJuly 2025 Snapshot & Entry Point Confirmation Signals - Fundação Cultural do Pará
Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim - Yahoo Finance
Visual analytics tools that track Mangoceuticals Inc. performanceMarket Performance Summary & Fast Moving Stock Watchlists - newser.com
Mangoceuticals Launches New Weight-Management Programs - TipRanks
Mangoceuticals down after denying Lilly, Novo deals (MGRX) - Seeking Alpha
Mangoceuticals Inc Clarifies Launch of GLP-1 Programs - TradingView
Investors Flee Mangoceuticals Stock (MGRX) after Eli Lilly and Novo Nordisk Deny Partnership - TipRanks
Novo Nordisk, Eli Lilly Say No Partnership on Weight-loss Drugs with Mangoceuticals - MarketScreener
Novo Nordisk, Eli Lilly deny partnership with Mangoceuticals on weight-loss drugs - WISH-TV
Mangoceuticals launches direct GLP-1 medication access programs By Investing.com - Investing.com Nigeria
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs - WTVB
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs - Reuters
Mangoceuticals says co has no direct contractual relationship with Eli Lilly or Novo Nordisk - MarketScreener
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs - The Manila Times
Mangoceuticals (NASDAQ: MGRX) offers $99/mo GLP-1 programs with Rx to Zepbound, Wegovy - Stock Titan
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs - GlobeNewswire Inc.
Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals - Fierce Pharma
Novo Nordisk, Eli Lilly Reject Partnership Claims by Mangoceuticals - MarketScreener
Mangoceuticals’ partnership with Eli Lilly and Novo Nordisk? News to them. - Sherwood News
Eli Lilly (LLY) Clarifies No Ties with Mangoceuticals - GuruFocus
Mangoceuticals stock tumbles after Novo Nordisk, Lilly deny partnership claims - Investing.com India
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs By Reuters - Investing.com
Mangoceuticals sinks after Novo Nordisk, Lilly deny obesity drugs partnership - TradingView
Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc. - MarketScreener
Mangoceuticals, Inc. (MGRX) Stock: Surges on Launch of Direct GLP-1 Access Programs - parameter.io
Novo Nordisk, Lilly Deny Partnership With Mangoceuticals on Obesity Drugs - US News Money
Analyzing Mangoceuticals Inc. with risk reward ratio chartsEarnings Overview Summary & Weekly Top Gainers Trade List - newser.com
Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs - ts2.tech
Why is MGRX Soaring? Find Out Now! - StocksToTrade
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.87%
1.29%
자본화:
|
볼륨(24시간):